Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 560

Results For "IND"

5663 News Found

Glenmark Life Sciences files for IPO
News | April 18, 2021

Glenmark Life Sciences files for IPO

The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals


Aceto acquires specialty exipients company A&C
News | April 16, 2021

Aceto acquires specialty exipients company A&C

Acquisition of A&C expands Aceto’s Western manufacturing footprint


IMPCL revenue crosses Rs. 160 crore
News | April 15, 2021

IMPCL revenue crosses Rs. 160 crore

Presently, IMPCL is manufacturing 656 classical Ayurvedic, 332 Unani and 71 proprietary Ayurvedic medicines for the various diseases spectrum


Pharma PLI to increase exports
Policy | April 14, 2021

Pharma PLI to increase exports

Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28


Merck publishes sustainability report for 2020
News | April 13, 2021

Merck publishes sustainability report for 2020

The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.


NATCO receives approval for Ibrutinib tablets from ANDA
News | April 11, 2021

NATCO receives approval for Ibrutinib tablets from ANDA

The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths


Aurore to merge with Solara in an all-stock transaction
News | April 10, 2021

Aurore to merge with Solara in an all-stock transaction

The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions


Hester to commercialize vaccines for animals
News | April 09, 2021

Hester to commercialize vaccines for animals

Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection


Pharma sector has both brainpower and manpower to drive growth: Mandaviya
Policy | April 09, 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable


Panacea to produce 100 mn doses of Sputnik V vaccine
News | April 06, 2021

Panacea to produce 100 mn doses of Sputnik V vaccine

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF